REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

MERLEGSOFT PHARMA Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: MERLEGSOFT PHARMA Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

MERLEGSOFT PHARMA Kft. is an enterprise in Hungary, with the main office in Kecskemet. The company operates in the Pharmacies and Drug Stores sector. The company was established on October 18, 2019. 6 (2024) employees currently work for MERLEGSOFT PHARMA Kft.. In its most recent financial highlights, the company reported a net sales revenue increase of 10.42% in 2023. Its total assets decreased by 11.02% over the same period. In 2023, MERLEGSOFT PHARMA Kft.’s net profit margin increased by 0.02%.

Headquarters
Kossuth utca 81/B
Kecskemet; Bacs-Kiskun; Postal Code: 6000

Contact Details: Purchase the MERLEGSOFT PHARMA Kft. report to view the information.

Basic Information
Total Employees:
Purchase the MERLEGSOFT PHARMA Kft. report to view the information.
Outstanding Shares:
Purchase the MERLEGSOFT PHARMA Kft. report to view the information.
Registered Capital:
Purchase the MERLEGSOFT PHARMA Kft. report to view the information.
Incorporation Date:
October 18, 2019
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after MERLEGSOFT PHARMA Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
10.42%▲
Total operating revenue
10.48%▲
Operating profit (EBIT)
11.98%▲
EBITDA
11.57%▲
Net Profit (Loss) for the Period
12.44%▲
Total assets
-11.02%▼
Total equity
-9.97%▼
Operating Profit Margin (ROS)
0.01%▲
Net Profit Margin
0.02%▲
Return on Equity (ROE)
9.38%▲
Quick Ratio
-0.1%▼
Cash Ratio
-0.12%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo